Authors: Pecora, AL Stiff, P LeMaistre, CF Bayer, R Bachier, C Goldberg, SL Parthasarathy, M Jennis, AA Smith, AK Douville, J Chen, B Armstrong, RD Mandalam, RK Preti, R

Citation: Al. Pecora et al., A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation, BONE MAR TR, 28(3), 2001, pp. 295-303

Authors: Pecora, AL Lazarus, HM Stadtmauer, EA Winter, J Van Vliet, A Berry, D Gray, R Jennis, A Goldberg, S Cooper, BW Preti, R

Citation: Al. Pecora et al., Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer, BONE MAR TR, 27(12), 2001, pp. 1245-1253

Authors: Yanovich, S Mitsky, P Cornetta, K Maziarz, RT Rosenfeld, C Krause, DS Lotz, JP Bitran, JD Williams, B Preti, R Somlo, G Burtness, B Mills, B

Citation: S. Yanovich et al., Transplantation of CD34(+) peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial, BONE MAR TR, 25(11), 2000, pp. 1165-1174

Authors: Ahmed, T Kancherla, R Qureshi, Z Mittelman, A Seiter, K Mannancheril, A Puccio, C Chun, HG Bar, M Lipshutz, M Ali, MF Goldberg, R Preti, R Lake, D Durrani, H Farley, T

Citation: T. Ahmed et al., High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34(+) selection to clinical outcome, BONE MAR TR, 25(10), 2000, pp. 1041-1045